SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 11, 2015 | Option Exercise | $8.68 | 4,348 | 37,741 | 111,328 | Dec 15, 2015, 05:12 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 12, 2015 | Option Exercise | $8.68 | 4,000 | 34,720 | 107,328 | Dec 15, 2015, 05:12 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 07, 2015 | Option Exercise | $9.69 | 6,087 | 58,983 | 115,676 | Dec 09, 2015, 04:53 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jun 05, 2015 | Sale | $7.87 | 30,000 | 236,144 | 111,763 | Jun 09, 2015, 05:26 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | May 05, 2015 | Sale | $7.87 | 30,000 | 236,048 | 110,376 | May 05, 2015, 07:26 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Apr 06, 2015 | Sale | $9.20 | 30,000 | 275,922 | 110,376 | Apr 08, 2015, 07:06 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Mar 05, 2015 | Sale | $10.87 | 30,000 | 326,032 | 110,376 | Mar 06, 2015, 06:49 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Feb 05, 2015 | Sale | $9.52 | 30,000 | 285,459 | 110,376 | Feb 06, 2015, 07:50 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jan 05, 2015 | Sale | $11.01 | 30,000 | 330,154 | 110,376 | Jan 06, 2015, 07:24 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 15, 2014 | Option Exercise | $14.74 | 27,480 | 405,006 | 95,376 | Dec 15, 2014, 09:23 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 05, 2014 | Sale | $9.02 | 30,000 | 270,497 | 112,856 | Dec 09, 2014, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Nov 05, 2014 | Sale | $8.47 | 30,000 | 254,135 | 112,856 | Nov 07, 2014, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Oct 06, 2014 | Option Exercise | $7.42 | 30,000 | 222,515 | 111,579 | Oct 08, 2014, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Sep 05, 2014 | Option Exercise | $8.16 | 30,000 | 244,722 | 111,579 | Sep 05, 2014, 09:45 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Aug 05, 2014 | Sale | $8.83 | 28,202 | 249,106 | 111,579 | Aug 05, 2014, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | May 27, 2014 | Option Exercise | $8.63 | 30,000 | 258,761 | 111,377 | May 29, 2014, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Apr 28, 2014 | Option Exercise | $8.66 | 30,000 | 259,762 | 110,015 | Apr 30, 2014, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Mar 26, 2014 | Option Exercise | $11.16 | 30,000 | 334,925 | 110,015 | Mar 28, 2014, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Feb 26, 2014 | Sale | $11.70 | 30,000 | 350,982 | 110,015 | Feb 28, 2014, 08:01 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jan 27, 2014 | Option Exercise | $11.13 | 30,000 | 333,959 | 110,015 | Jan 29, 2014, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 26, 2013 | Option Exercise | $9.02 | 30,000 | 270,707 | 110,015 | Dec 30, 2013, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 12, 2013 | Option Exercise | $12.12 | 14,783 | 179,170 | 97,015 | Dec 13, 2013, 08:03 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Nov 26, 2013 | Sale | $7.86 | 30,000 | 235,948 | 100,798 | Nov 29, 2013, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Oct 28, 2013 | Sale | $7.14 | 30,000 | 214,349 | 98,798 | Oct 30, 2013, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Sep 26, 2013 | Option Exercise | $7.24 | 30,000 | 217,144 | 96,798 | Sep 30, 2013, 08:00 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Aug 26, 2013 | Option Exercise | $7.16 | 28,000 | 200,536 | 97,798 | Aug 28, 2013, 08:01 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jul 26, 2013 | Sale | $7.19 | 28,000 | 201,238 | 99,798 | Jul 30, 2013, 04:20 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | May 28, 2013 | Option Exercise | $5.97 | 30,000 | 178,968 | 103,798 | May 30, 2013, 04:31 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Apr 26, 2013 | Option Exercise | $7.16 | 30,000 | 214,896 | 103,798 | Apr 29, 2013, 06:16 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Mar 26, 2013 | Option Exercise | $6.40 | 30,000 | 191,874 | 103,798 | Mar 28, 2013, 05:44 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Feb 26, 2013 | Option Exercise | $6.13 | 30,000 | 183,750 | 103,798 | Feb 28, 2013, 06:15 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jan 28, 2013 | Option Exercise | $6.64 | 30,000 | 199,308 | 103,798 | Feb 28, 2013, 06:11 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jan 28, 2012 | Option Exercise | $6.64 | 30,000 | 199,308 | 103,798 | Jan 30, 2013, 04:17 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Dec 26, 2012 | Option Exercise | $4.84 | 32,000 | 154,868 | 103,798 | Dec 28, 2012, 04:06 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Nov 26, 2012 | Sale | $5.33 | 4,736 | 25,232 | 55,798 | Nov 28, 2012, 07:35 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Nov 27, 2012 | Option Exercise | $4.60 | 30,000 | 138,150 | 70,798 | Nov 28, 2012, 07:35 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Oct 26, 2012 | Sale | $4.80 | 35,000 | 168,085 | 78,534 | Oct 29, 2012, 09:53 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Oct 15, 2012 | Sale | $5.66 | 5,000 | 28,283 | 67,534 | Oct 17, 2012, 05:58 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Sep 05, 2012 | Option Exercise | $4.60 | 30,000 | 138,150 | 83,534 | Sep 06, 2012, 05:51 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Aug 27, 2012 | Sale | $5.18 | 5,000 | 25,903 | 72,364 | Aug 29, 2012, 07:07 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jul 26, 2012 | Sale | $5.06 | 5,000 | 25,320 | 77,534 | Jul 30, 2012, 04:58 PM |
SGMO | | SANGAMO BIOSCIENCES INC | ANDO DALE G | VP, Therapeutic Dev. & CMO | Jul 27, 2012 | Sale | $4.60 | 30,000 | 138,150 | 88,534 | Jul 30, 2012, 04:58 PM |